HDAC inhibition by butyrate also modulates multiple pathways, including AKT/ERK and JAK2/STAT3, thereby suppressing invasion in CRC as well as proliferation and angiogenesis in myeloproliferative tumors 114,115. The gene discussed is AKT1; the disease is colorectal carcinoma.